» Articles » PMID: 26673553

Transforming Growth Factor Beta 1 Modulates the Functional Expression of the Neurokinin-1 Receptor in Human Keratocytes

Overview
Journal Curr Eye Res
Publisher Informa Healthcare
Specialty Ophthalmology
Date 2015 Dec 18
PMID 26673553
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Transforming growth factor beta 1 (TGF-β1) is a cytokine involved in a variety of processes, such as differentiation of fibroblasts into myofibroblasts. TGF-β1 has also been shown to delay the internalization of the neurokinin-1 receptor (NK-1 R) after its activation by its ligand, the neuropeptide substance P (SP). NK-1 R comprises two naturally occurring variants, a full-length and a truncated form, triggering different cellular responses. SP has been shown to affect important events in the cornea - such as stimulating epithelial cell proliferation - processes that are involved in corneal wound healing and thus in maintaining the transparency of the corneal stroma. An impaired signaling through NK-1 R could thus impact the visual quality. We hypothesize that TGF-β1 modulates the expression pattern of NK-1 R in human corneal stroma cells, keratocytes. The purpose of this study was to test that hypothesis.

Methods: Cultures of primary keratocytes were set up with cells derived from healthy human corneas, obtained from donated transplantation graft leftovers, and characterized by immunocytochemistry and Western blot. Immunocytochemistry for TGF-β receptors and NK-1 R was performed. Gene expression was assessed with real-time polymerase chain reaction (qPCR).

Results: Expression of TGF-β receptors was confirmed in keratocytes in vitro. Treating the cells with TGF-β1 significantly reduced the gene expression of NK-1 R. Furthermore, immunocytochemistry for NK-1 R demonstrated that it is specifically the expression of the full-length isotype of the receptor that is reduced after treatment with TGF-β1, which was also confirmed with qPCR using a specific probe for the full-length receptor.

Conclusions: TGF-β1 down-regulates the gene expression of the full-length variant of NK-1 R in human keratocytes, which might impact its signaling pathway and thus explain the known delay in internalization after activation by SP seen with TGF-β1 treatment.

Citing Articles

Seeding of breast cancer cell line (MDA-MB-231) to the mandible induces overexpression of substance P and CGRP throughout the trigeminal ganglion and widespread peripheral sensory neuropathy throughout all three of its divisions.

Gutierrez S, Eisenach J, Boada M Mol Pain. 2021; 17:17448069211024082.

PMID: 34229504 PMC: 8267036. DOI: 10.1177/17448069211024082.


Gatifloxacin inducing apoptosis of stromal fibroblasts through cross-talk between caspase-dependent extrinsic and intrinsic pathways.

Xu B, Sui Y, Fan T Int J Ophthalmol. 2019; 12(10):1524-1530.

PMID: 31637186 PMC: 6796086. DOI: 10.18240/ijo.2019.10.02.


Cross-talk between the transcription factor Sp1 and C/EBPβ modulates TGFβ1 production to negatively regulate the expression of chemokine RANTES.

Sakamoto A, Yamaguchi R, Yamaguchi R, Narahara S, Sugiuchi H, Yamaguchi Y Heliyon. 2018; 4(7):e00679.

PMID: 29998198 PMC: 6037877. DOI: 10.1016/j.heliyon.2018.e00679.


The effects of substance P and acetylcholine on human tenocyte proliferation converge mechanistically via TGF-β1.

Fong G, Backman L, Alfredson H, Scott A, Danielson P PLoS One. 2017; 12(3):e0174101.

PMID: 28301610 PMC: 5354451. DOI: 10.1371/journal.pone.0174101.

References
1.
Eckes B, Zweers M, Zhang Z, Hallinger R, Mauch C, Aumailley M . Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. J Investig Dermatol Symp Proc. 2006; 11(1):66-72. DOI: 10.1038/sj.jidsymp.5650003. View

2.
Tomasek J, Gabbiani G, Hinz B, Chaponnier C, Brown R . Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002; 3(5):349-63. DOI: 10.1038/nrm809. View

3.
Watanabe M, Nakayasu K, Iwatsu M, Kanai A . Endogenous substance P in corneal epithelial cells and keratocytes. Jpn J Ophthalmol. 2003; 46(6):616-20. DOI: 10.1016/s0021-5155(02)00617-2. View

4.
Bron A . The architecture of the corneal stroma. Br J Ophthalmol. 2001; 85(4):379-81. PMC: 1723930. DOI: 10.1136/bjo.85.4.379. View

5.
Fini M, Stramer B . How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes. Cornea. 2005; 24(8 Suppl):S2-S11. DOI: 10.1097/01.ico.0000178743.06340.2c. View